News

Thanks to the addition of a cutting-edge radiotherapy treatment, patients at Good Samaritan Hospital now have access to one of the newest tools in the fight against cancer.

The hospital’s TrueBeam Linear Accelerator system enables doctors and staff to take a radically different approach to treating cancer, thanks to image-guided radiotherapy.

Dr. Shawn Zimberg, medical director, Dr. John Rescigno, associate medical director, and Dr. Raman Kaul currently treat patients at Good Samaritan Hospital using the hospital’s new system.

Read the full article on dailyvoice.com

In this interview, Shawn Zimberg, MD, and Dean Laganosky, MD, discuss the BioProtect Balloon Transplant System, a rectal spacer that received FDA clearance in August 2023 for use during prostate cancer radiation.¹ Zimberg–a radiation oncologist and medical director at Advanced Radiation Centers (ARC) of New York, a division of Integrated Medical Professionals (IMP)–performed the first procedures in the US in October 2023. Laganosky–a urologist with MidLantic Urology (MLU)–performed his first procedures in November 2023, becoming the first to do so in Pennsylvania. Both IMP and MLU are affiliates of Solaris Health.

Read the full article.

Lake Success, NY – Advanced Urology Centers of New York (AUCNY), a division of Integrated Medical Professionals, and an affiliate of Solaris Health is proud to announce the recognitions received for both their clinical excellence and the patient experience provided.

Castle Connolly Top Doctors, named AUCNY as the#1 Urology Practice in the nation.  The selection is made based on nominations by health care professionals and determined by a rigorous verification process. You cannot ask to be chosen, nor can you purchase your way onto the list. The Castle Connolly roster includes doctors who are best-in-class healthcare professionals, who exemplify clinical care excellence and who have the skills to build patient relationships.

AUCNY’s commitment to compassionate patient care has been verified by the 15.6K patient reviews received in less than a year. Rater8, a leading reputation management company has ranked AUCNY as the “Highest Rated in Overall Practice Excellence” (with 20+ doctors) for providing outstanding patient experiences.

“I am extremely proud that in addition to the recognition by Castle Connolly, Advanced Urology Centers of New has earned the rater8 “Practice Excellence Award for “Highest Rated in Overall Practice Excellence,” the large group category for “going above and beyond in creating the best patient experience possible,” says Deepak A. Kapoor, MD, Market President of Integrated Medical Professionals, headquartered in Lake Success, New York.

For questions or an appointment, visit the AUCNY website at www.aucofny.com.

About Advanced Urology Centers of New York: Advanced Urology Centers of New York (AUCNY), a division of Integrated Medical Professionals (IMP), has been recognized as the #1 Urology Practice in the nation for clinical excellence and for Patient Excellence.

AUCNY has 35+ locations in Nassau, Suffolk, Queens, Manhattan, The Bronx, Westchester, and Rockland County. Their caregivers are committed to patient satisfaction, and strive to provide comprehensive, compassionate, and personalized urological care using state-of-the-art technology and evidence-based practices.

To learn more about Advanced Urology Centers of New York, visit www.aucofny.com.

As healthcare providers hone their strategies for strengthening access to care, improving health outcomes, and satisfying patients, innovative cancer testing and personalized medicine are increasingly at the forefront. Solaris Health, a national healthcare platform, is one such organization that is helping to advance those aims.

Becker’s Hospital Review recently spoke with two clinical leaders at Solaris Health about their decision to bring hereditary cancer testing in-house for its affiliates:

• Deepak Kapoor, MD, Solaris Health chair, chief ecosystem officer and president of Integrated Medical Professionals (IMP), Solaris’ New York Metro Market affiliate; and
• Kathleen Latino, MD, Solaris Health chief medical officer and IMP’s medical director.

Read the article here.

We are pleased to announce that Integrated Medical Professionals is the proud recipient of the 2023 rater8 Practice Excellence Award for Highest Rated Practice Overall!

Rater8’s annual awards recognize practices and providers who demonstrated outstanding commitment to delivering unparalleled patient experiences. Recognition is based on the internal ratings collected via rater8 surveys, which saw 5.7 million questions answered in 2023.

We thank rater8 for this recognition, and will continue to dedicate ourselves to the highest possible standard for patient experience and practice improvement! Please join us in celebrating this achievement, and visit rater8’s blog to check out the official announcement: https://rater8.com/blog/2023-practice-excellence-awards/

Physicians at medical practices affiliated with Solaris Health, the nation’s leading healthcare management company in the urological field, are the first throughout the country to provide a new technology that substantially enhances safety for patients undergoing radiation therapy for prostate cancer.

LAKE SUCCESS, N.Y. (November 2, 2023) – Prostate cancer patients treated at Advanced Radiation Centers of New York (ARC) became the first in the United States to benefit from the implantation of a novel biodegradable rectal spacer – The BioProtect Balloon Implant System. These pioneering implant procedures were performed by Dr. Shawn H. Zimberg, Medical Director at ARC, a division of Integrated Medical Professionals (IMP). IMP is a Solaris Health affiliate.

As the prostate and rectum are separated by mere millimeters, the rectum is at risk for collateral damage during radiation therapy for prostate cancer, potentially leading to serious and sometimes sustained side effects. The only prior solution to decrease radiation exposure to the rectum during prostate cancer radiation was to inject a synthetic gel-like material to create a “space” to separate the prostate and rectum. Now, rather than a gel, the novel biodegradable pre-formed saline-filled BioProtect Balloon® can create nearly double the protective space between the prostate and rectum during radiation therapy.

“We know that creating space separating the prostate and rectum decreases rectal complications, as well as urinary and sexual risks that can occur following prostate radiation therapy,” Dr. Zimberg stated, adding, “So by creating an even larger and symmetrical space that the BioProtect Balloon achieves, we expect to see even more improvements in patient safety.”

Developed by medical device maker BioProtect, Ltd., the BioProtect Balloon Spacer received clearance from the United States Food and Drug Administration in August of this year. The BioProtect Balloon spacer is a pre-defined shape, creating a symmetric and reproducible space, which is not typically achievable with gel spacers. In addition, the BioProtect Balloon spacer fully dissolves within six months, much faster than the currently available gel-based spacers.

To date, 35 patients have received this novel therapy. Dr. Zimberg continued, “This technology is truly game-changing – the predictable shape of the BioProtect Balloon spacer vastly improves radiation planning and delivery, further enhancing safety benefits for our patients.”

Thomas Schmidt, a 63-year-old elite wellness travel agent from Rockville Centre, NY, is among the initial recipients of the balloon spacer. “First and foremost, I want to be cured of prostate cancer,” Schmidt said. “Beyond that, I feel fortunate to have had this new technology, which will make my treatments safer and more predictable.”

Dr. Deepak Kapoor, Chair and Chief Ecosystem Officer of Solaris Health, stated, “Doctors at practices affiliated with Solaris are committed to providing their patients access to cutting-edge technologies that both enhance safety and improve outcomes. We’re proud that Solarisaffiliated practices and their providers across the country will be among the first to offer this important adjunct to radiation therapy protocols.” ARC’s Dr. Zimberg also serves as National Director of Radiation Oncology for Solaris Health.

BioProtect CEO Itay Barnea underscored the significance of the adoption of his company’s balloon spacer system by Dr. Zimberg and other radiation oncologists and urologists at Solarisaffiliated practices. “This is an invaluable opportunity for us to work with a group of doctors who are national leaders in elevating quality of care and in pursuing the most advanced technologies to treat prostate cancer,” Barnea said.

There are 288,300 new cases of prostate cancer a year in the United States and 34,700 deaths from prostate cancer, according to the American Cancer Society. Prostate cancer is the second leading cause of cancer death in American men, behind lung cancer. Thomas Schmidt and other men who are initial recipients of the BioProtect Balloon Spacer have non-metastatic and potentially curable prostate cancers.

About Advanced Radiation Centers of New York
Advanced Radiation Centers of New York (“ARC”) is the largest freestanding radiation oncology facility in the New York metropolitan and neighboring Tri-State area, treating all forms of cancer in eight state-of-the-art cancer treatment facilities.

About Solaris Health
Solaris Health is the leading U.S. healthcare management company in the urological field. Its affiliated medical practices have over 625 providers who annually care for over 885,000 unique patients in 13 states. These practices and their providers are committed to enhancing access to specialty healthcare and continually improving patient outcomes. Empowering community providers allows them to make sure that every decision they make puts patient care at the forefront. Solaris Health is growing to meet the changing needs of healthcare providers, and to help them develop innovative ways to better deliver value and state-of-the-art care to their patients. Solaris Health is proud to be among the most innovative healthcare management companies in the United States. Visit www.solarishealthpartners.com.

About BioProtect
BioProtect is a technology platform company that provides innovative biodegradable spacing solutions. BioProtect’s first application, commercially available in the US and Europe, is the BioProtect Balloon Implant System, a new generation spacer designed to provide optimal, consistent, and reproducible protection to the rectum during prostate cancer radiation therapy. For more information about BioProtect and their products, please visit www.BioProtect.com.

Download the Press Release PDF

77WABC Remembers Bernard McGuirk One Year Later Presented By Advanced Radiation Centers of New York: Special Guest Dr. Shawn Zimberg

Listen to the podcast here.